Follow
Deborah Sneddon
Deborah Sneddon
Postdoctoral Researcher
Verified email at chem.ox.ac.uk
Title
Cited by
Cited by
Year
Synthesis and in Vivo Biological Evaluation of 68Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography
D Sneddon, R Niemans, M Bauwens, A Yaromina, SJA Van Kuijk, ...
Journal of medicinal chemistry 59 (13), 6431-6443, 2016
412016
Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance
EMC Tacconi, S Badie, G De Gregoriis, T Reisländer, X Lai, M Porru, ...
EMBO molecular medicine 11 (7), e9982, 2019
352019
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor
A Skwarska, EDD Calder, D Sneddon, H Bolland, ML Odyniec, IN Mistry, ...
Cell chemical biology 28 (9), 1258-1270. e13, 2021
242021
Emerging chelators for nuclear imaging
D Sneddon, B Cornelissen
Current Opinion in Chemical Biology 63, 152-162, 2021
222021
Selective NaOH-catalysed hydration of aromatic nitriles to amides
TE Schmid, A Gómez-Herrera, O Songis, D Sneddon, A Révolte, F Nahra, ...
Catalysis Science & Technology 5 (5), 2865-2868, 2015
222015
Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expression
D Sneddon, SA Poulsen
Journal of enzyme inhibition and medicinal chemistry 29 (5), 753-763, 2014
202014
Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)
EDD Calder, A Skwarska, D Sneddon, LK Folkes, IN Mistry, SJ Conway, ...
Tetrahedron 76 (21), 131170, 2020
192020
Zap‐Pano: a Photocaged Prodrug of the KDAC Inhibitor Panobinostat
KS Troelsen, EDD Calder, A Skwarska, D Sneddon, EM Hammond, ...
ChemMedChem 16 (24), 3691-3700, 2021
62021
A model system to explore the detection limits of antibody-based immuno-SPECT imaging of exclusively intranuclear epitopes
M Veal, G Dias, V Kersemans, D Sneddon, S Faulkner, B Cornelissen
Journal of Nuclear Medicine 62 (11), 1537-1544, 2021
62021
The design, synthesis, and evaluation of hypoxia-activated prodrugs of the KDAC inhibitor panobinostat
E Calder, A Skwarska, D Sneddon, L Folkes, IN Mistry, EM Hammond, ...
2020
Exploring the limits of intranuclear PET/SPECT imaging with IgG-TAT: how low can you go?
M Veal, GM Dias, V Kersemans, D Sneddon, S Faulkner, B Cornelissen
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 47 (SUPPL 1), S78-S78, 2020
2020
Development of novel Ga-68 chelators for PET imaging
D Sneddon, WT Stuber, S Faulkner, B Cornelissen
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019
2019
Development of novel 68Ga chelators for PET imaging
D Sneddon, W Stuber, S Faulkner, B Cornelissen
EANM'19, 2019
2019
Prospects of 31P Contrast Media for 31P-MRS
LR Tear, ML Maguire, G Karunanithy, D Sneddon, NJ Farrer, A Baldwin, ...
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018, 2018
2018
99mTc-duramycin imaging reveals variable tissue toxicity of cancer drugs
D Sneddon, JBĂ Torres, S Badie, M Tarsounas, B Cornelissen
Journal of Nuclear Medicine 59 (supplement 1), 1286-1286, 2018
2018
DEVELOPMENT OF IMAGING AGENTS TO TARGET TUMOUR HYPOXIA
D SNEDDON
2016
Catalysis Science & Technology RSCPublishing
TE Schmid, A Gómez-Herrera, O Songis, D Sneddon, A Révolte, F Nahra, ...
The system can't perform the operation now. Try again later.
Articles 1–17